Current
Neuro-Oncology


Volume 22 Number 2
February 2020


Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 2, February


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS




GLIOMAS


BRAIN STEM GLIOMAS


HIGH-GRADE GLIOMAS


LOW-GRADE GLIOMAS




DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


DIFFUSE ASTROCYTOMA


GLIOBLASTOMA


DIFFUSE MIDLINE GLIOMA




EPENDYMAL TUMORS




EMBRYONAL TUMORS


ATYPICAL THERATOID/RHABDOID TUMOR




METASTATIC TUMORS





CENTRAL NERVOUS SYSTEM TUMORS


Fujii M, Ichikawa M, Iwatate K, Bakhit M, Yamada M, Kuromi Y, Sato T, Sakuma J, Sato H, Kikuta A, Suzuki Y, Saito K.
Secondary brain tumors after cranial radiation therapy: A single-institution study.
Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):245-249. doi: 10.1016/j.rpor.2020.01.009. Epub 2020 Jan 30.
Source _ Similar articles




Fujita Y, Kohta M, Sasayama T, et al.
Intraoperative 3-T Magnetic Resonance Spectroscopy for Detection of Proliferative Remnants of Glioma.
World Neurosurg. 2020;137:149–157. doi:10.1016/j.wneu.2020.01.217. [published online ahead of print, 2020 Feb 5].
Source _ Similar articles




Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD; PCAWG Evolution & Heterogeneity Working Group, Spellman PT, Wedge DC, Van Loo P; PCAWG Consortium.
The evolutionary history of 2,658 cancers.
Nature. 2020 Feb;578(7793):122-128. doi: 10.1038/s41586-019-1907-7. Epub 2020 Feb 5.
Source _ Similar articles




Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, Dörfler A, Engelhorn T, Eyüpoglu I, Rühle PF, Putz F, Semrau S, Gaipl US, Fietkau R.
Early mortality of brain cancer patients and its connection to cytomegalovirus reactivation during radiochemotherapy.
Clin Cancer Res. 2020 Feb 14:clincanres.3195.2019. doi: 10.1158/1078-0432.CCR-19-3195. Epub ahead of print.
Source _ Similar articles




Grist JT, Withey S, MacPherson L, et al.
Distinguishing between paediatric brain tumour types using multi-parametric magnetic resonance imaging and machine learning: A multi-site study.
Neuroimage Clin. 2020;25:102172. doi:10.1016/j.nicl.2020.102172. Available online 23 January 2020.
Source _ Similar articles




Kramer K, Donzelli M, Nwora E, Pandit-Taskar N.
Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
J Nucl Med. 2020 Jan 31:jnumed.119.232678. doi: 10.2967/jnumed.119.232678. Epub ahead of print.
Source _ Similar articles



GLIOMAS


Gao X, Zhang Z, Mashimo T, Shen B, Nyagilo J, Wang H, Wang Y, Liu Z, Mulgaonkar A, Hu XL, Piccirillo SGM, Eskiocak U, Davé DP, Qin S, Yang Y, Sun X, Fu YX, Zong H, Sun W, Bachoo RM, Ge WP.
Gliomas Interact with Non-glioma Brain Cells via Extracellular Vesicles.
Cell Rep. 2020 Feb 25;30(8):2489-2500.e5. Doi: 10.1016/j.celrep.2020.01.089.
Source _ Similar articles




Wang Z, Zhong L, Li G, Huang R, Wang Q, Wang Z, Zhang C, Chen B, Jiang T, Zhang W.
Pre-treatment neutrophils count as a prognostic marker to predict chemotherapeutic response and survival outcomes in glioma: a single-center analysis of 288 cases.
Am J Transl Res. 2020 Jan 15;12(1):90-104.
Source _ Similar articles




Zhao Z, Zhang C, Li M, Shen Y, Feng S, Liu J, Li F, Hou L, Chen Z, Jiang J, Ma X, Chen L, Yu X.
Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
Jpn J Clin Oncol. 2020 Mar 9;50(3):325-332. doi:10.1093/jjco/hyz156.
Source _ Similar articles



BRAIN STEM GLIOMAS



Solís-Nolasco IM, Caraballo G, González MJ, Olalde J, Morales-Borges RH.
Impact of Intravenous Vitamin C and Endolaser Therapies on a Pediatric Brainstem Glioma Case.
Glob Adv Health Med. 2020 Jan 15;9:2164956120901489. doi:10.1177/2164956120901489.
Source _ Similar articles



HIGH-GRADE GLIOMAS



Bauer EK, Stoffels G, Blau T, et al.
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET.
Eur J Nucl Med Mol Imaging. 2020;10.1007/s00259-020-04695-0. doi:10.1007/s00259-020-04695-0 [published online ahead of print, 2020 Feb 7].
Source _ Similar articles




Dissaux G, Basse V, Schick U, El Kabbaj O, Auberger B, Magro E, Kassoul A, Abgral R, Salaun PY, Bourhis D, Querellou S.
Prognostic value of 18F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma.
Medicine (Baltimore). 2020 Jan 31;99(5):e19017. doi: 10.1097/MD.0000000000019017.
Source _ Similar articles




Muto J, Matsutani T, Matsuda R, Kinoshita M, Oikawa M, Pallud J, Sasaki H.
Temozolomide radiochemotherapy for high-grade glioma patients with hemodialysis: a case series of 7 patients.
Neurooncol Pract. 2020 Jan;7(1):111-117. doi:10.1093/nop/npz034. Epub 2019 Dec 3.
Source _ Similar articles




Roux A, Pallud J, Saffroy R, Edjlali-Goujon M, Debily MA, Boddaert N, Sanson M, Puget S, Knafo S, Adam C, Faillot T, Cazals-Hatem D, Mandonnet E, Polivka M, Dorfmüller G, Dauta A, Desplanques M, Gareton A, Pages M, Tauziede-Espariat A, Grill J, Bourdeaut F, Doz F, Dhermain F, Mokhtari K, Chretien F, Figarella-Branger D, Varlet P.
High-grade gliomas in adolescents and young adults highlight histomolecular differences with their adult and paediatric counterparts.
Neuro Oncol. 2020 Feb 6. doi: 10.1093/neuonc/noaa024. [Epub ahead of print]
Source _ Similar articles




Wick A, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Felsberg J, Weyerbrock A, Papsdorf K, Steinbach JP, Sabel M, Vesper J, Debus J, Meixensberger J, Ketter R, Hertler C, Mayer-Steinacker R, Weisang S, Bölting H, Reuss D, Reifenberger G, Sahm F, von Deimling A, Weller M, Wick W; NOA-08 Study Group of the Neurooncology Working Group (NOA) of the German Cancer Society.
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter-methylated malignant astrocytoma.
Neuro Oncol. 2020 Feb 17:noaa033. doi: 10.1093/neuonc/noaa033. Epub ahead of print.
Source _ Similar articles




Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M; NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society.
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
Lancet Oncol. 2012 Jul;13(7):707-15. doi: 10.1016/S1470-2045(12)70164-X. Epub 2012 May 10.
Source _ Similar articles



LOW-GRADE GLIOMAS



Acharya S, Liu JF, Tatevossian RG, Chiang J, Qaddoumi I, Gajjar A, Walker D, Harreld J, Merchant TE, Ellison DW.
Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: An integrated clinicopathologic and molecular analysis.
Neuro Oncol. 2020 Feb 13:noaa031. doi:10.1093/neuonc/noaa031. Epub ahead of print.
Source _ Similar articles




Breen WG, Anderson SK, Carrero XW, Brown PD, Ballman KV, O'Neill BP, Curran WJ, Abrams RA, Laack NN, Levitt R, Galanis E, Buckner JC, Shaw EG.
Final report from intergroup NCCTG 86-72-51 (Alliance): a phase 3 randomized clinical trial of high dose versus low dose radiation for adult low-grade glioma.
Neuro Oncol. 2020 Jan 30:noaa021. doi: 10.1093/neuonc/noaa021. Epub ahead of print.
Source _ Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



DIFFUSE ASTROCYTOMA



Choi J, Kim SH, Ahn SS, et al.
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma.
Sci Rep. 2020;10(1):2086. Published 2020 Feb 7. doi:10.1038/s41598-020-59089-x
Source _ Similar articles



GLIOBLASTOMA



Al-Holou WN, Hodges TR, Everson RG, Freeman J, Zhou S, Suki D, Rao G, Ferguson SD, Heimberger AB, McCutcheon IE, Prabhu SS, Lang FF, Weinberg JS, Wildrick DM, Sawaya R.
Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.
Neurosurgery. 2020 Jan 1;86(1):112-121. doi: 10.1093/neuros/nyz008.
Source _ Similar articles




Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Harsh GR, Adler JR, Harrahar C, Li G, Hayden Gephart M, Nagpal S, Thomas RP, Recht LD, Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von Eyben R, Choi CYH, Soltys SG.
A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes.
Neuro Oncol. 2020 Jan 31:noaa019. doi: 10.1093/neuonc/noaa019. Epub ahead of print.
Source _ Similar articles




Baehr A, Trog D, Oertel M, Welsch S, Kröger K, Grauer O, Haverkamp U, Eich HT.
Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts.
Strahlenther Onkol. 2020 Feb 3. doi: 10.1007/s00066-020-01585-0. [Epub ahead of print]
Source _ Similar articles




Belter A, Barciszewski J, Barciszewska AM.
Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions.
PLoS One. 2020 Feb 26;15(2):e0229534. doi: 10.1371/journal.pone.0229534.
Source _ Similar articles




Choi BD, Gerstner ER, Curry WT Jr.
A Common Rule for Resection of Glioblastoma in the Molecular Era.
JAMA Oncol. 2020 Feb 6. doi: 10.1001/jamaoncol.2019.6384. [Epub ahead of print]
Source _ Similar articles
Referring to: Molinaro AM, et al., Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol. 2020 Feb 6. doi: 10.1001/jamaoncol.2019.6143. Epub ahead of print. Source _ Similar articles




Daghighi S, Bahrami N, Tom WJ, Coley N, Seibert TM, Hattangadi-Gluth JA, Piccioni DE, Dale AM, Farid N, McDonald CR.
Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma.
Front Oncol. 2020 Jan 28;10:24. doi:10.3389/fonc.2020.00024.
Source _ Similar articles




Das S, Sahgal A, Perry JR.
Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Front Oncol. 2020 Jan 31;10:66. doi: 10.3389/fonc.2020.00066.
Source _ Similar articles




Garrett AM, Lastakchi S, McConville C.
The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study.
Genes (Basel). 2020;11(2):E173. Published 2020 Feb 6. doi:10.3390/genes11020173.
Source _ Similar articles




Georgescu MM, Olar A.
Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma.
Acta Neuropathol Commun. 2020 Feb 3;8(1):10. doi: 10.1186/s40478-020-0889-x.
Source _ Similar articles




Hata N, Mizoguchi M, Kuga D, Hatae R, Akagi Y, Sangatsuda Y, Amemiya T, Michiwaki Y, Fujioka Y, Takigawa K, Suzuki SO, Yoshitake T, Togao O, Hiwatashi A, Yoshimoto K, Iihara K.
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide.
J Neurooncol. 2020 Feb;146(3):451-458. doi: 10.1007/s11060-019-03339-0. Epub 2020 Feb 4.
Source _ Similar articles




Himes BT, Arnett A, Merrell KW, Gates M, Bhargav AG, Raghunathan A, Brown DA, Burns TC, Parney IF.
Glioblastoma recurrence versus treatment effect in a pathology-documented series.
Can J Neurol Sci. 2020 Feb 20:1-18. doi: 10.1017/cjn.2020.36. Epub ahead of print.
Source _ Similar articles




Huang YK, Lieu AS.
Treatment response of bevacizumab combination chemotherapy in recurrent glioblastoma: A long-term retrospective study in Taiwan.
Medicine (Baltimore). 2020 Feb;99(8):e19226. doi: 10.1097/MD.0000000000019226.
Source _ Similar articles




Ius T, Pignotti F, Della Pepa GM, La Rocca G, Somma T, Isola M, Battistella C, Gaudino S, Polano M, Dal Bo M, Bagatto D, Pegolo E, Chiesa S, Arcicasa M, Olivi A, Skrap M, Sabatino G.
A Novel Comprehensive Clinical Stratification Model to Refine Prognosis of Glioblastoma Patients Undergoing Surgical Resection.
Cancers (Basel). 2020 Feb 7;12(2):E386. doi: 10.3390/cancers12020386.
Source _ Similar articles




Ius T, Pignotti F, Della Pepa GM, Bagatto D, Isola M, Battistella C, Gaudino S, Pegolo E, Chiesa S, Arcicasa M, La Rocca G, Olivi A, Skrap M, Sabatino G.
Glioblastoma: from volumetric analysis to molecular predictors.
J Neurosurg Sci. 2020 Feb 4. doi: 10.23736/S0390-5616.20.04850-X. Epub ahead of print..
Source _ Similar articles




Killock D.
Extent of resection is important across glioblastoma molecular subtypes.
Nat Rev Clin Oncol. 2020 Feb 20. doi: 10.1038/s41571-020-0344-8. Epub ahead of print.
Source _ Similar articles
Referring to: Molinaro AM, et al., Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol. 2020 Feb 6. doi: 10.1001/jamaoncol.2019.6143. Epub ahead of print. Source _ Similar articles




Kim CY, Paek SH, Nam DH, Chang JH, Hong YK, Kim JH, Kim OL, Kim SH.
Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
J Neurooncol. 2020 Feb;146(3):399-406. doi: 10.1007/s11060-019-03361-2. Epub 2020 Feb 4.
Source _ Similar articles




Larsson C, Groote I Jr II, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A.
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
Magn Reson Imaging. 2020 Jan 28;68:106-112. doi: 10.1016/j.mri.2020.01.012. Epub ahead of print.
Source _ Similar articles




Moiyadi A, Shetty P, Sridhar E, Gota V, Gurjar M, Saicharan G, Singh V, Srivastava S.
Objective assessment of intraoperative tumor fluorescence reveals biological heterogeneity within glioblastomas: a biometric study.
J Neurooncol. 2020 Feb;146(3):477-488. doi: 10.1007/s11060-019-03338-1. Epub 2020 Feb 4.
Source _ Similar articles




Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS.
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
JAMA Oncol. 2020 Feb 6. doi: 10.1001/jamaoncol.2019.6143. Epub ahead of print.
Source _ Similar articles




Müther M, Stummer W.
Commentary: Perilesional Resection of Glioblastoma is Independently Associated With Improved Outcomes.
Neurosurgery. 2020 Feb 28:nyaa045. doi: 10.1093/neuros/nyaa045. Epub ahead of print.
Source _ Similar articles




Pierscianek D, Ahmadipour Y, Michel A, Chihi M, Oppong MD, Kebir S, Glas M, Stuschke M, Sure U, Jabbarli R.
Prediction of Preoperative Survival in Patients With Glioblastoma by Routine Inflammatory Laboratory Parameters.
Anticancer Res. 2020 Feb;40(2):1161-1166. doi: 10.21873/anticanres.14058..
Source _ Similar articles




Reardon DA, Desjardins A, Vredenburgh JJ, et al.
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
Clin Cancer Res. 2020;10.1158/1078-0432.CCR-18-1140. doi:10.1158/1078-0432.CCR-18-1140 [published online ahead of print, 2020 Feb 7].
Source _ Similar articles




Stachelek GC, Grimm J, Moore J, Huang E, Spoleti N, Redmond KJ, Lim M, Bettegowda C, Kleinberg L.
Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy.
Adv Radiat Oncol. 2019 Aug 28;5(1):62-69. doi: 10.1016/j.adro.2019.08.005.
Source _ Similar articles




Yamaki T, Shibahra I, Matsuda KI, Kanemura Y, Konta T, Kanamori M, Yamakawa M, Tominaga T, Sonoda Y.
Relationships between recurrence patterns and subventricular zone involvement or CD133 expression in glioblastoma.
J Neurooncol. 2020 Feb;146(3):489-499. doi: 10.1007/s11060-019-03381-y. Epub 2020 Feb 4.
Source _ Similar articles




Yang F, Zou Y, Gong Q, Chen J, Li WD, Huang Q.
From astrocytoma to glioblastoma: a clonal evolution study.
FEBS Open Bio. 2020 Feb 18. doi: 10.1002/2211-5463.12815. Epub ahead of print.
Source _ Similar articles




Valiakhmetova A, Gorelyshev S, Konovalov A, Trunin Y, Savateev A, Kram DE, Severson E, Hemmerich A, Edgerly C, Duncan D, Britt N, Huang RSP, Elvin J, Miller V, Ross JS, Gay L, McCorkle J, Rankin A, Erlich RL, Chudnovsky Y, Ramkissoon SH.
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
Oncologist. 2020 Feb;25(2):e198-e202. doi: 10.1634/theoncologist.2019-0603. Epub 2019 Oct 16.
Source _ Similar articles




Wang QT, Nie Y, Sun SN, Lin T, Han RJ, Jiang J, Li Z, Li JQ, Xiao YP, Fan YY, Yuan XH, Zhang H, Zhao BB, Zeng M, Li SY, Liao HX, Zhang J, He YW.
Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.
Cancer Immunol Immunother. 2020 Feb 20. doi: 10.1007/s00262-020-02496-w. Epub ahead of print.
Source _ Similar articles




Werlenius K, Fekete B, Blomstrand M, Carén H, Jakola AS, Rydenhag B, Smits A.
Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients.
PLoS One. 2020 Feb 13;15(2):e0228480. doi: 10.1371/journal.pone.0228480.
Source _ Similar articles




Wick W, Wagener RJ. Not Yet Another Negative Trial-ReACTing on Recent Glioblastoma Trials!
Clin Cancer Res. 2020;10.1158/1078-0432.CCR-19-4032. doi:10.1158/1078-0432.CCR-19-4032 [published online ahead of print, 2020 Feb 7].
Source _ Similar articles
Referring to: Reardon DA, Desjardins A, Vredenburgh JJ, et al., Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial. Clin Cancer Res. 2020;10.1158/1078-0432.CCR-18-1140. doi:10.1158/1078-0432.CCR-18-1140 [published online ahead of print, 2020 Feb 7]. Source _ Similar articles



DIFFUSE MIDLINE GLIOMA



Baxter PA, Su JM, Onar-Thomas A, Billups CA, Li XN, Poussaint TY, Smith ER, Thompson PA, Adekunsle A, Ansell P, Giranda VL, Paulino AC, Kilburn L, Quaddoumi I, Broniscer A, Blaney SM, Dunkel IJ, Fouladi M.
A Phase I/II Study of Veliparib (ABT-888) with Radiation and Temozolomide in Newly Diagnosed Diffuse Pontine Glioma: A Pediatric Brain Tumor Consortium Study.
Neuro Oncol. 2020 Feb 3:noaa016. doi: 10.1093/neuonc/noaa016. Epub ahead of print.
Source _ Similar articles




Tinkle CL, Campbell K, Han Y, Li Y, Bianski B, Broniscer A, Khan RB, Merchant TE.
Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
J Neurooncol. 2020 Feb 3. doi: 10.1007/s11060-020-03415-w. [Epub ahead of print]
Source _ Similar articles



EPENDYMAL TUMORS


Liu SJ, Magill ST, Vasudevan HN, Hilz S, Villanueva-Meyer JE, Lastella S, Daggubati V, Spatz J, Choudhury A, Orr BA, Demaree B, Seo K, Ferris SP, Abate AR, Oberheim Bush NA, Bollen AW, McDermott MW, Costello JF, Raleigh DR.
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma.
Cell Rep. 2020 Feb 4;30(5):1300-1309.e5. doi: 10.1016/j.celrep.2020.01.018.
Source _ Similar articles



EMBRYONAL TUMORS



ATYPICAL THERATOID/RHABDOID TUMOR



Reddy AT, Strother DR, Judkins AR, Burger PC, Pollack IF, Krailo MD, Buxton AB, Williams-Hughes C, Fouladi M, Mahajan A, Merchant TE, Ho B, Mazewski CM, Lewis VA, Gajjar A, Vezina LG, Booth TN, Parsons KW, Poss VL, Zhou T, Biegel JA, Huang A.
Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333.
J Clin Oncol. 2020 Feb 27:JCO1901776. Doi: 10.1200/JCO.19.01776. Epub ahead of print.
Source _ Similar articles



METASTATIC TUMORS


Schatlo B, Stockhammer F, Barrantes-Freer A, Bleckmann A, Siam L, Pukrop T, Rohde V.
5-Aminolevulinic Acid Fluorescence Indicates Perilesional Brain Infiltration in Brain Metastases.
World Neurosurg X. 2019 Dec 16;5:100069. doi: 10.1016/j.wnsx.2019.100069.
Source _ Similar articles



bottom